Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,269 public trials 1,192 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors

NCT04045496

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +55 more
Locations
  • HealthONE Clinic Services Oncology-Hematology Denver, Colorado, United States
  • Tennessee Oncology, PLLC Nashville, Tennessee, United States
  • The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
  • Washington University School of Medicine Seattle, Washington, United States
View Trial Details
Completed

Study of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung Cancer

NCT03810807

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Completed

Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy

NCT04471428

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Stanford University Palo Alto, California, United States
  • Kaiser Permanente - San Diego San Diego, California, United States
  • Sansum Clinic Santa Barbara, California, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
View all 92 locations
View Trial Details
Completed

Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients

NCT00213798

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Service de Pneumologie, Hôpital Lyautey Strasbourg, France
  • Service de Chirurgie Thoracique, Hôpital Civil Strasbourg, France
  • Service de Pneumologie, Hôpital Civil Strasbourg, France
  • Service de Pneumologie, Hôpital de Hautepierre Strasbourg, France
View Trial Details
Completed

A Study of Amivantamab and Lazertinib in People With Non-Small Cell Lung Cancer (NSCLC)

NCT04965090

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Completed

A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC

NCT03215706

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Memorial Health Systems Colorado Springs, Colorado, United States
  • Local Institution - 0044 Plainville, Connecticut, United States
  • Local Institution - 0045 Jacksonville, Florida, United States
  • Local Institution - 0029 Marietta, Georgia, United States
View all 116 locations
View Trial Details
Completed

Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors

NCT04349267

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +22 more
Locations
  • Local Institution - 0028 Sioux Falls, South Dakota, United States
  • Local Institution - 0001 Germantown, Tennessee, United States
  • Local Institution - 0014 Edmonton, Alberta, Canada
  • Local Institution - 0011 Vancouver, British Columbia, Canada
View Trial Details
Completed

Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer

NCT02621398

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions